Clinical Trial Update: Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care

View source ↗

Summary

This clinical trial update reports on four bone turnover markers in multiple myeloma patients treated with intravenous bisphosphonates in routine care; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Intravenous bisphosphonates (bisphosphonates (intravenous))

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Multiple Myeloma | Status: TERMINATED